Meeder Advisory Services Inc. bought a new stake in CME Group Inc. (NASDAQ:CME – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 7,337 shares of the financial services provider’s stock, valued at approximately $1,620,000.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Whipplewood Advisors LLC raised its position in shares of CME Group by 2,075.0% in the 1st quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 83 shares during the period. Elkhorn Partners Limited Partnership acquired a new position in CME Group during the fourth quarter valued at approximately $27,000. Hilton Head Capital Partners LLC bought a new stake in CME Group in the fourth quarter valued at approximately $28,000. Legacy Wealth Managment LLC ID increased its stake in CME Group by 191.9% in the fourth quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 71 shares in the last quarter. Finally, Anfield Capital Management LLC raised its holdings in CME Group by 197.4% in the fourth quarter. Anfield Capital Management LLC now owns 113 shares of the financial services provider’s stock worth $31,000 after purchasing an additional 75 shares during the period. Institutional investors own 87.75% of the company’s stock.
Wall Street Analyst Weigh In
A number of brokerages have recently weighed in on CME. Wall Street Zen cut shares of CME Group from a “sell” rating to a “strong sell” rating in a research report on Saturday, August 1st. UBS Group reduced their target price on CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a report on Monday, July 6th. Bank of America boosted their target price on CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a research note on Thursday, July 23rd. Deutsche Bank Aktiengesellschaft downgraded CME Group from a “buy” rating to a “hold” rating and lowered their price target for the stock from $286.00 to $270.00 in a report on Wednesday. Finally, Weiss Ratings cut CME Group from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, August 11th. Nine research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $288.56.
Insiders Place Their Bets
In other CME Group news, Director William R. Shepard purchased 325 shares of the firm’s stock in a transaction dated Thursday, June 25th. The stock was bought at an average cost of $230.57 per share, with a total value of $74,935.25. Following the purchase, the director directly owned 260,442 shares of the company’s stock, valued at $60,050,111.94. The trade was a 0.12% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. 0.30% of the stock is currently owned by company insiders.
CME Group Price Performance
Shares of NASDAQ CME opened at $266.94 on Thursday. The company has a fifty day moving average price of $250.89 and a 200 day moving average price of $279.81. The firm has a market cap of $95.99 billion, a PE ratio of 22.64, a PEG ratio of 3.16 and a beta of 0.23. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 1-year low of $218.31 and a 1-year high of $329.16.
CME Group (NASDAQ:CME – Get Free Report) last released its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.91 by $0.08. The firm had revenue of $1.71 billion for the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company’s revenue for the quarter was up .8% on a year-over-year basis. During the same quarter last year, the business posted $2.96 EPS. Research analysts predict that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.
CME Group Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be paid a $1.30 dividend. The ex-dividend date is Wednesday, September 9th. This represents a $5.20 annualized dividend and a yield of 1.9%. CME Group’s payout ratio is presently 44.11%.
About CME Group
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Recommended Stories
- Five stocks we like better than CME Group
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
